Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Bailey

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 28, 2012
Grapefruit-medication interactions: forbidden fruit or avoidable consequences?David G Bailey, George Dresser, J Malcolm O Arnold
Clinical Pharmacology and Therapeutics|March 1, 2005
Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptidesGeorge K Dresser, Richard B Kim, David G Bailey
Clinical Pharmacology and Therapeutics|September 18, 2002
Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivoGeorge K Dresser, Vincent Wacher, Susan Wong, et al.
Archives of Drug Information|February 17, 2010
Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by PravastatinYu Asanuma, Annette Oeser, Eran Stanley, et al.
American Journal of Hypertension|August 3, 2016
Coffee-Antihypertensive Drug Interaction: A Hemodynamic and Pharmacokinetic Study With FelodipineDavid G Bailey, George K Dresser, Brad L Urquhart, et al.
British Journal of Clinical Pharmacology|September 26, 2006
Impact of citrus soft drinks relative to grapefruit juice on ciclosporin dispositionUte I Schwarz, Philip E Johnston, David G Bailey, et al.
BMJ Open|March 7, 2020
Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic studyMarc L Chretien, David G Bailey, Linda Asher, et al.
JAMA|December 19, 2013
Calcium-channel blocker-clarithromycin drug interactions and acute kidney injurySonja Gandhi, Jamie L Fleet, David G Bailey, et al.
BMJ Open|February 24, 2023
Severity of coeliac disease and clinical management study when using a non-metabolised medication: a phase I pharmacokinetic studyMarc L Chretien, David G Bailey, Linda Asher, et al.
Pharmacology Research & Perspectives|October 4, 2017
Coffee inhibition of CYP3A4 in vitro was not translated to a grapefruit-like pharmacokinetic interaction clinicallyGeorge K Dresser, Brad L Urquhart, Julianne Proniuk, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 28, 2012
Grapefruit-medication interactions: forbidden fruit or avoidable consequences?David G Bailey, George Dresser, J Malcolm O Arnold
Clinical Pharmacology and Therapeutics|March 1, 2005
Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptidesGeorge K Dresser, Richard B Kim, David G Bailey
Clinical Pharmacology and Therapeutics|September 18, 2002
Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivoGeorge K Dresser, Vincent Wacher, Susan Wong, et al.
Archives of Drug Information|February 17, 2010
Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by PravastatinYu Asanuma, Annette Oeser, Eran Stanley, et al.
American Journal of Hypertension|August 3, 2016
Coffee-Antihypertensive Drug Interaction: A Hemodynamic and Pharmacokinetic Study With FelodipineDavid G Bailey, George K Dresser, Brad L Urquhart, et al.
British Journal of Clinical Pharmacology|September 26, 2006
Impact of citrus soft drinks relative to grapefruit juice on ciclosporin dispositionUte I Schwarz, Philip E Johnston, David G Bailey, et al.
BMJ Open|March 7, 2020
Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic studyMarc L Chretien, David G Bailey, Linda Asher, et al.
JAMA|December 19, 2013
Calcium-channel blocker-clarithromycin drug interactions and acute kidney injurySonja Gandhi, Jamie L Fleet, David G Bailey, et al.
BMJ Open|February 24, 2023
Severity of coeliac disease and clinical management study when using a non-metabolised medication: a phase I pharmacokinetic studyMarc L Chretien, David G Bailey, Linda Asher, et al.
Pharmacology Research & Perspectives|October 4, 2017
Coffee inhibition of CYP3A4 in vitro was not translated to a grapefruit-like pharmacokinetic interaction clinicallyGeorge K Dresser, Brad L Urquhart, Julianne Proniuk, et al.
Pageof 3